JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB248915

Anti-HOXA9 antibody [EPR3655(2)] - BSA and Azide free

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Monoclonal HOXA9 antibody. Carrier free. Suitable for WB, IP and reacts with Human samples.

View Alternative Names

HOX1G, HOXA9, Homeobox protein Hox-A9, Homeobox protein Hox-1G

2 Images
Immunoprecipitation - Anti-HOXA9 antibody [EPR3655(2)] - BSA and Azide free (AB248915)
  • IP

Supplier Data

Immunoprecipitation - Anti-HOXA9 antibody [EPR3655(2)] - BSA and Azide free (AB248915)

Lane 1 : Wild-type HEK-293 input Lane 2 : HOXA9 knockout HEK-293 input Lane 3 : Wild-type HEK-293 immunoprecipitated with anti-HOXA9 antibody ab140631 Lane 4 : HOXA9 knockout HEK-293 immunoprecipitated with anti-HOXA9 antibody ab140631 Lane 5 : Wild-type HEK-293 immunoprecipitated with isotype control antibody ab172730 Lane 6 : HOXA9 knockout HEK-293 immunoprecipitated with isotype control antibody ab172730 HOXA9 was immunoprecipitated with Recombinant Anti-HOXA9 antibody [EPR3655(2)] (ab140631) at 10 µg ml-1. A non-specific band detected in the input material at 37 kDa was not immunoprecipitated. ab172730 was used as the isotype control. Western blot was performed on immunoprecipitates of wild-type and HOXA9 knockout HEK-293 cell lysates (ab273706). To generate this image, wild-type and HOXA9 knockout HEK-293 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with VeriBlot for IP Detection Reagent (HRP) (ab131366) for 1 h at room temperature, washed again four times then imaged. This data was developed using the same antibody clone in a different buffer formulation (ab140631).

All lanes:

Immunoprecipitation - Anti-HOXA9 antibody [EPR3655(2)] (<a href='/en-us/products/primary-antibodies/hoxa9-antibody-epr36552-ab140631'>ab140631</a>) at 10 µg/mL

Lane 1:

Wild-type HEK-293 input

Lane 2:

HOXA9 knockout HEK-293 input

Lane 3:

Wild-type HEK-293 immunoprecipitated with anti-HOXA9 antibody <a href='/en-us/products/primary-antibodies/hoxa9-antibody-epr36552-ab140631'>ab140631</a>

Lane 4:

HOXA9 knockout HEK-293 immunoprecipitated with anti-HOXA9 antibody <a href='/en-us/products/primary-antibodies/hoxa9-antibody-epr36552-ab140631'>ab140631</a>

Lane 5:

Wild-type HEK-293 immunoprecipitated with isotype control antibody <a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a>

Lane 6:

HOXA9 knockout HEK-293 immunoprecipitated with isotype control antibody <a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a>

Secondary

All lanes:

Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>)

Predicted band size: 30 kDa

false

Western blot - Anti-HOXA9 antibody [EPR3655(2)] - BSA and Azide free (AB248915)
  • WB

Lab

Western blot - Anti-HOXA9 antibody [EPR3655(2)] - BSA and Azide free (AB248915)

This data was developed using ab140631, the same antibody clone in a different buffer formulation.

Western blot : Anti-HOXA9 antibody [EPR3655(2)] (ab140631) staining at 1/1000 dilution, shown in black; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab140631 was shown to bind specifically to HOXA9. A band was observed at 30 kDa in wild-type HCT 116 cell lysates with no signal observed at this size in HOXA9 knockout cell line. To generate this image, wild-type and HOXA9 knockout HCT 116 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development with a high-sensitivity ECL substrate kit and imaged with 1 minute exposure time. Secondary antibodies used were HRP conjugated Goat anti-Rabbit (H+L) and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-HOXA9 antibody [EPR3655(2)] (<a href='/en-us/products/primary-antibodies/hoxa9-antibody-epr36552-ab140631'>ab140631</a>) at 1/1000 dilution

Lane 1:

Wild-type HCT 116 cell lysate at 20 µg

Lane 2:

Western blot - Human HOXA9 knockout HCT116 cell line (<a href='/en-us/products/cell-lines/human-hoxa9-knockout-hct116-cell-line-ab287488'>ab287488</a>)

Lane 2:

HOXA9 knockout HCT 116 cell lysate at 20 µg

Secondary

Lanes 1 - 2:

HRP conjugated Goat anti-Rabbit (H+L) at 1/20000 dilution

Lanes 1 - 2:

Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 30 kDa

false

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR3655(2)

Isotype

IgG

Carrier free

Yes

Reacts with

Human

Applications

IP, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>" }, "Mouse": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "" } } }

Product details

ab248915 is the carrier-free version of ab140631.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

HOXA9 also known as Homeobox A9 functions as a transcription factor and plays an important role in regulating gene expression during embryonic development and hematopoiesis. The protein has a mass of approximately 27 kDa. It shows expression in hematopoietic progenitor cells as well as in certain tissues like the lungs and the central nervous system. By binding to specific DNA sequences HOXA9 regulates genes that are vital for cellular differentiation and proliferation.
Biological function summary

HOXA9 controls the transition and lineage commitment of hematopoietic stem cells. The protein often interacts as part of a transcriptional complex involving other HOX family proteins to maintain proper gene expression balance. This regulatory function is essential for normal gene expression patterns needed in stem cell differentiation and organ development processes.

Pathways

HOXA9 plays significant roles in the hematopoietic cell lineage and the retinoic acid signaling pathway. Through these pathways it collaborates with other HOX proteins like HOXB4 to maintain stem cell properties and influence the differentiation process. These interactions facilitate the production of necessary blood cell types and ensure effective response mechanisms to various developmental cues.

HOXA9 shows a strong connection with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Overexpression or mutation of HOXA9 disturbs normal hematopoietic processes often leading to these malignancies. The interaction with protein PBX1 also highlights its role in these diseases as their joint involvement frequently appears in leukemogenesis. Understanding how HOXA9 contributes to these pathways is critical for developing targeted therapeutic strategies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Required for induction of SELE/E-selectin and VCAM1 on the endothelial cells surface at sites of inflammation (PubMed : 22269951). Positively regulates EIF4E-mediated mRNA nuclear export and also increases the translation efficiency of ODC mRNA in the cytoplasm by competing with factors which repress EIF4E activity such as PRH (By similarity).
See full target information HOXA9

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com